Nothing wrong with using a xenogeneic nude mouse/rat model to prove proof of concept with properly controlled experiments, assuming of course that the target tumour is human-derived. In addition, I would expect that PYC has used a human breast cancer cell line for their in-vitro studies; again, OK for proof of concept. Nevertheless, I'd like to see some hard data soon.
- Forums
- ASX - By Stock
- Silliness
Nothing wrong with using a xenogeneic nude mouse/rat model to...
- There are more pages in this discussion • 176 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.003(3.09%) |
Mkt cap ! $466.6M |
Open | High | Low | Value | Volume |
9.9¢ | 10.5¢ | 9.9¢ | $588.9K | 5.868M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 332000 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 1589749 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32000 | 0.100 |
1 | 30612 | 0.098 |
1 | 6289 | 0.097 |
1 | 5593 | 0.096 |
5 | 208500 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 1589749 | 6 |
0.115 | 711700 | 4 |
0.120 | 1789122 | 7 |
0.125 | 320000 | 2 |
0.130 | 500000 | 1 |
Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
Last
10.0¢ |
  |
Change
0.003 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
10.0¢ | 10.3¢ | 10.0¢ | 436833 | ||
Last updated 15.52pm 17/05/2024 ? |
Featured News
PYC (ASX) Chart |